IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Palo Alto Investors LP

Q1 2023 Holdings

Filed 2023-05-15 | 30 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$178.0M1,831,03514.8%
Revance Therapeutics Inc(RVNCEUR)COM761330109$169.8M5,270,20914.1%
United Therapeutics Corp(UTHR)COM91307C102$140.5M627,51411.6%
Amicus Therapeutics Inc(FOLD)COM03152W109$116.7M10,524,0229.7%
Biogen Inc(BIIB)COM09062X103$106.0M381,2828.8%
Insmed Inc(INSM)COM457669307$100.4M5,889,4918.3%
Staar Surgical Co(STAA)COM852312305$86.2M1,347,3227.1%
Prothena Corp PLC(PRTA)COMG72800108$80.6M1,663,7776.7%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$45.3M2,405,7933.8%
Sage Therapeutics Inc(SG7)COM78667J108$36.1M859,5173.0%
Ehealth Inc(EHTH)COM28238P109$25.2M2,689,3792.1%
Align Technology Inc(ALGN)COM016255101$24.9M74,6052.1%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$22.1M5,675,8761.8%
Alkermes PLC(ALKS)COMG01767105$17.0M603,4001.4%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$12.9M612,6001.1%
Provention BIO Inc(PRVBUSD)COM74374N102$9.4M390,8000.8%
Anaptysbio Inc(ANAB)COM032724106$9.4M431,2240.8%
Gossamer BIO Inc(GOSS)COM38341P102$4.4M3,465,1520.4%
Cytokinetics Inc(CYTK)COM23282W605$3.9M111,7170.3%
Travere Therapeutics Inc(TVTX)COM89422G107$3.7M166,0690.3%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$3.3M482,6970.3%
Kezar Life Sciences IncCOM49372L100$2.1M656,2000.2%
Novocure LTD(NVCR)COMG6674U108$2.0M32,7900.2%
Gritstone Oncology Inc(2JQ)COM39868T105$1.9M666,1270.2%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$1.6M160,8000.1%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$1.6M64,7000.1%
Relmada Therapeutics Inc(RLMD)COM75955J402$1.2M542,1000.1%
Tactile Systems Technology I(TCMD)COM87357P100$445.0K27,1000.0%
Peak BIO IncCOM70470P108$314.1K497,5280.0%
Urogen Pharma LTD(URGN)COMM96088105$226.4K24,5000.0%